NO741309L - Analogifremgangsmåte ved fremstilling av terapeutisk aktive seco-prostaglandiner. - Google Patents

Analogifremgangsmåte ved fremstilling av terapeutisk aktive seco-prostaglandiner.

Info

Publication number
NO741309L
NO741309L NO741309A NO741309A NO741309L NO 741309 L NO741309 L NO 741309L NO 741309 A NO741309 A NO 741309A NO 741309 A NO741309 A NO 741309A NO 741309 L NO741309 L NO 741309L
Authority
NO
Norway
Prior art keywords
seco
prostaglandins
preparation
therapeutically active
analogous process
Prior art date
Application number
NO741309A
Other languages
English (en)
Other versions
NO139438C (no
NO139438B (no
Inventor
Jr Edward Jethro Cragoe
James Holden Jones
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO741309L publication Critical patent/NO741309L/no
Publication of NO139438B publication Critical patent/NO139438B/no
Publication of NO139438C publication Critical patent/NO139438C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/19Acids containing three or more carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
NO74741309A 1973-04-25 1974-04-09 Analogifremgangsmaate ved fremstilling av terapeutisk aktive seco-prostaglandiner NO139438C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35427373A 1973-04-25 1973-04-25
US41834173A 1973-11-23 1973-11-23

Publications (3)

Publication Number Publication Date
NO741309L true NO741309L (no) 1974-10-28
NO139438B NO139438B (no) 1978-12-04
NO139438C NO139438C (no) 1979-03-14

Family

ID=26998324

Family Applications (1)

Application Number Title Priority Date Filing Date
NO74741309A NO139438C (no) 1973-04-25 1974-04-09 Analogifremgangsmaate ved fremstilling av terapeutisk aktive seco-prostaglandiner

Country Status (14)

Country Link
JP (1) JPS5013331A (no)
AR (1) AR211319A1 (no)
BE (1) BE814089A (no)
CA (1) CA1044701A (no)
CH (1) CH605714A5 (no)
DE (1) DE2419860A1 (no)
ES (1) ES425591A1 (no)
FR (1) FR2226995B1 (no)
GB (1) GB1429092A (no)
IE (1) IE39227B1 (no)
IL (1) IL44636A (no)
NL (1) NL7404839A (no)
NO (1) NO139438C (no)
SE (1) SE410185B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991087A (en) 1973-12-13 1976-11-09 Merck & Co., Inc. 8-Halo-11,12-secoprostaglandins
AT351182B (de) * 1974-06-25 1979-07-10 Merck & Co Inc Verfahren zur herstellung von neuen 9-thia-, 9-oxothia- und 9-dioxothia- 11,12-secoprosta- glandinen
US4018802A (en) * 1975-04-09 1977-04-19 Merck & Co., Inc. 9-Thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins and processes
US4128564A (en) * 1976-03-22 1978-12-05 Merck & Co., Inc. 9-Thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins

Also Published As

Publication number Publication date
IE39227L (en) 1974-10-25
CH605714A5 (no) 1978-10-13
IL44636A (en) 1977-06-30
ES425591A1 (es) 1976-11-01
FR2226995A1 (no) 1974-11-22
DE2419860A1 (de) 1974-11-07
AR211319A1 (es) 1977-11-20
GB1429092A (en) 1976-03-24
SE410185B (sv) 1979-10-01
CA1044701A (en) 1978-12-19
NO139438C (no) 1979-03-14
BE814089A (fr) 1974-10-24
AU6797374A (en) 1975-10-23
NO139438B (no) 1978-12-04
IL44636A0 (en) 1974-06-30
FR2226995B1 (no) 1977-01-28
JPS5013331A (no) 1975-02-12
NL7404839A (no) 1974-10-29
IE39227B1 (en) 1978-08-30

Similar Documents

Publication Publication Date Title
NO741815L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive etylenderivater.
NO740137L (no) Analogifremgangsmåte ved fremstilling av terapeutisk virksomme karboksylsyrederivater.
NO741227L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive penicillinderivater.
NO143940C (no) Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenyl-alaninalkylestere
NO740272L (no) Analogifremgangsmåte til fremstilling av 3-substituerte 4-fenylpiperidiner.
NO740543L (no) Analogifremgangsmåte ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater.
NO142894C (no) Fremgangsmaate ved fremstilling av polyethylenterefthalatfilm
NO741140L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktiv 3-(4-p-fluorfenyl-1-metylbutyl)-1-hydroksy-6,6,9-trimetyl-7,8,9,10-tetrahydro-6H-dibenzo(b,d)pyran.
NO741125A (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater.
NO740675L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme dotriacontapeptidamider.
NO741223L (no) Fremgangsmåte for fremstilling av 6-deoksytetracykliner.
NO740405L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater.
NO740546L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme tripeptider.
NO740327L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive imidazopyridiner.
NO740694L (no) Analogifremgangsmåte til fremstilling av nye terapeutisk aktive kondenserte N-fenylsubstituerte pyrroler.
NO740349L (no) Analogifremgangsmåte ved fremstilling av antibakterielt virksomme piperazinderivater.
NO741607L (no) Fremgangsmåte for fremstilling av isocyanater.
NO741486L (no) Fremgangsmåte for fremstilling av xylitol.
NO741364L (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive pyrazolon-(5)-forbindelser.
NO740184L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 2-(fenoksyalkyltio)imidazolforbindelser.
FI49827C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi.
NO740614L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser.
NO741142L (no) Analogifremgangsmåte ved fremstilling av et terapeutisk aktivt benzopyranderivat.
NO741350L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive benzylaminer.
NO147754C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.